[Development and outlook on human challenge trial of vaccine].
Zhonghua Liu Xing Bing Xue Za Zhi
; 42(8): 1371-1375, 2021 Aug 10.
Article
in Chinese
| MEDLINE | ID: covidwho-1468526
ABSTRACT
Human challenge trial (HCT) is a test in which human volunteers are intentionally infected with pathogens in order to evaluate the efficacy of candidate preventive or therapeutic drugs. During the COVID-19 pandemic, the HCT of vaccines has aroused people's attention due to its significant advantages over clinical trial. This paper introduces the concept, development and application of HCT, the advantages and limitations of HCT for vaccine evaluation, and the consideration of future HCT of COVID-19 vaccine in China.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Vaccines
/
COVID-19
Type of study:
Experimental Studies
/
Prognostic study
/
Randomized controlled trials
Topics:
Vaccines
Limits:
Humans
Language:
Chinese
Journal:
Zhonghua Liu Xing Bing Xue Za Zhi
Year:
2021
Document Type:
Article
Affiliation country:
Cma.j.cn112338-20210506-00368
Similar
MEDLINE
...
LILACS
LIS